Executives from Amgen (NASDAQ:AMGN) highlighted broad-based commercial growth, a set of six “key growth drivers,” and several late-stage pipeline programs during a conference session hosted by Leerink ...

The new TrumpRx website is now live, and a number of medications have seen a sizeable decrease in cost. Here are some of the ...

Leerink Global Healthcare Conference 2026 March 11, 2026 9:20 AM EDTCompany ParticipantsJasper Van GrunsvenPeter Griffith - Executive ...

Wall Street is drawing fresh lines across the large-cap biopharma landscape, initiating coverage on two stocks and maintaining an overweight rating on another.

Why Amgen (AMGN) is on investors’ radar today Amgen (AMGN) is back in focus after recent share price moves, with the stock ...

Investing.com - 杰富瑞(Jefferies)首次覆盖安进公司(Amgen Inc.)(NASDAQ:AMGN),给予持有评级,并将目标价设定为$350,该报告于周一发布。 该公司表示,安进股票在当前水平上估值合理。杰富瑞指出,该公司面临99亿美元的专利到期缺口,但可以通过基础业务增长来抵消。 分析师表示,从当前水平上涨取决于心脏代谢管线的乐观情况,包括MariTide和olpasi ...

Danish experts now fear that more pharma companies will withdraw medicines from Denmark to avoid being penalised in the US market ...

Former Vertex executive to spearhead the clinical development of Absci’s expanding AI-designed therapeutics pipeline ...

Former Vertex executive to spearhead the clinical development of Absci's expanding AI-designed therapeutics pipeline Chief Innovation Officer Andreas Busch to retire March 31, 2026 and will continue ...

Amgen (NASDAQ:AMGN) executives highlighted broad-based commercial momentum, a focus on long-term growth drivers, and several upcoming pipeline milestones during a fireside chat at the 46th Annual TD ...

2026年3月2日星期一,安进公司 (NASDAQ:AMGN)在TD Cowen第46届年度医疗保健会议上进行了展示。该公司强调了其2025年的强劲表现,主要得益于关键产品的强劲增长,同时也提到了2026年可能面临的挑战,包括市场动态和竞争压力。

TD Cowen 46th Annual Health Care Conference March 2, 2026 1:10 PM ESTCompany ParticipantsKave Niksefat - Senior Vice President of ...